Blog
RSS FeedPosted by Michael Wonder on 16 May 2024
As childhood asthma worsens, insurers restrict access to an essential medication
16 May 2024 - As paediatricians who take care of children in the inpatient, emergency, and primary care settings, we ...
Posted by Michael Wonder on 14 May 2024
Budget 2024–25: cheaper medicines, new Medicare Urgent Care Clinics and more free mental health services in a stronger Medicare
14 May 2024 - The Albanese Labor Government is continuing to improve our health system: strengthening Medicare, the heart of universal ...
Posted by Michael Wonder on 13 May 2024
Boehringer Ingelheim expands access to adalimumab-adbm injection, the company's biosimilar to Humira
13 May 2024 - Boehringer Ingelheim announced an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient ...
Posted by Michael Wonder on 13 May 2024
First ever life-saving treatment for rare heart condition available on the NHS
13 May 2024 - NHS patients with a life-threatening heart condition are set to benefit from a cutting-edge new medicine ...
Posted by Michael Wonder on 13 May 2024
Australians benefit from new life changing medicines added to the PBS
13 May 2024 - Women with endometrial cancer and people with itching associated with chronic kidney disease will benefit from ...
Posted by Michael Wonder on 10 May 2024
Celltrion USA's adalimumab-aaty biosimilar to Humira now available at low wholesale acquisition cost
9 May 2024 - Adalimumab-aaty will be priced at an 85% discount to Humira (adalimumab). ...
Posted by Michael Wonder on 09 May 2024
Government adds two new heart disease treatments on the PBS
9 May 2024 - Australians with different types of cardiomyopathies now have access to new treatments under the Pharmaceutical Benefits Scheme. ...
Posted by Michael Wonder on 08 May 2024
First patient begins newly approved sickle cell gene therapy
6 May 2024 - On Wednesday, Kendric Cromer, a 12 year old boy from a suburb of Washington, became the ...
Posted by Michael Wonder on 05 May 2024
PHARMAC and Health NZ weigh up future of COVID-19 vaccines and treatments
3 May 2024 - PHARMAC and Health NZ are weighing up the future direction of COVID-19 vaccinations and treatments in ...
Posted by Michael Wonder on 05 May 2024
Vyndamax (tafamidis) PBS listed for adult patients with wild type or hereditary transthyretin amyloid cardiomyopathy with New York Heart Association class I-II heart failure
4 May 2024 - The availability of Vyndamax on the PBS provides subsidised access to a once daily oral single ...
Posted by Michael Wonder on 03 May 2024
NHS rolls out ‘life-changing’ treatment for thousands with sickle cell disease
3 May 2024 - Thousands of patients with sickle cell disorder are to be offered a new “life-changing” treatment on ...
Posted by Michael Wonder on 03 May 2024
Enhertu to get insurance coverage for metastatic breast/stomach cancer from April
29 March 2024 - Starting next month, health insurance benefits will be applied to treating metastatic breast and gastric cancers ...
Posted by Michael Wonder on 30 Apr 2024
New Zealand Pharmaceutical Schedule - 1 May 2024
1 May 2024 - The May 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Apr 2024
Schedule of Pharmaceutical Benefits - 1 May 2024
1 May 2024 - The May 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Apr 2024
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA approved subcutaneous infliximab Zymfentra
28 April 2024 - Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's ...